(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 36.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 293.19%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.2%.
Fortress Biotech's revenue in 2025 is $59,301,000.On average, 4 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,262,700,192, with the lowest FBIO revenue forecast at $1,994,758,641, and the highest FBIO revenue forecast at $2,521,268,995. On average, 4 Wall Street analysts forecast FBIO's revenue for 2026 to be $3,267,964,522, with the lowest FBIO revenue forecast at $3,048,969,540, and the highest FBIO revenue forecast at $3,461,667,964.
In 2027, FBIO is forecast to generate $4,409,951,942 in revenue, with the lowest revenue forecast at $4,236,779,280 and the highest revenue forecast at $4,539,682,665.